Microglial Phenotypes and Their Relationship to the Cannabinoid System: Therapeutic Implications for Parkinson’s Disease
Parkinson’s disease is a neurodegenerative disorder, the motor symptoms of which are associated classically with Lewy body formation and nigrostriatal degeneration. Neuroinflammation has been implicated in the progression of this disease, by which microglia become chronically activated in...
Main Authors: | Rachel Kelly, Valerie Joers, Malú G. Tansey, Declan P. McKernan, Eilís Dowd |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-01-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/3/453 |
Similar Items
-
Editorial: Cannabinoids in neuroinflammation, neurodegeneration and pain: Focus on non-neuronal cells
by: Haley A. Vecchiarelli, et al.
Published: (2022-12-01) -
Time-Course of Alterations in the Endocannabinoid System after Viral-Mediated Overexpression of α-Synuclein in the Rat Brain
by: Rachel Kelly, et al.
Published: (2022-01-01) -
The Interplay between Cannabinoid Receptors and Microglia in the Pathophysiology of Alzheimer’s Disease
by: Rebecca Ferrisi, et al.
Published: (2023-11-01) -
Epigenetic Regulation of Neuroinflammation in Parkinson’s Disease
by: Madiha Rasheed, et al.
Published: (2021-05-01) -
Microglia and astrocyte dysfunction in parkinson's disease
by: Tae-In Kam, et al.
Published: (2020-10-01)